Lake Street is pleased to announce that it provided a fairness opinion to Envoy Medical Corporation on its announced definitive merger agreement with Anzu Special Acquisition Corp I (NasdaqCM:ANZU). Under the terms of the transaction, Envoy shareholders will receive 15 million shares of Anzu Class A Common Stock valued at $10.00 per share. Upon closing of the Merger, Anzu will change its name to “Envoy Medical, Inc.”
About Envoy Medical Corporation
Envoy Medical Corporation is a privately held hearing health company focused on providing innovative technologies across the hearing loss spectrum. Envoy Medical has pioneered one-of-a-kind, fully implanted devices for hearing loss, including its fully implanted Esteem® active middle ear implant, commercially available in the U.S. since 2010, and the fully implanted Acclaim® Cochlear Implant, an investigational device. Envoy Medical is dedicated to pushing hearing technology beyond the status quo to improve access, usability, compliance and ultimately quality of life.
About Anzu Special Acquisition Corp I
The Company is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The Company intends to focus on high-quality businesses with transformative technologies for industrial applications.